BioSymetrics
BioSymetrics is a phenomics-driven drug discovery founded in 2015 by Anthony Iacovone.
1
Funding Rounds
$5.9m
Money raised
Overview
BioSymetrics is a phenomics-driven drug discovery founded in 2015 by Anthony Iacovone.
-
Website:
- Business model: B2B
- Social accounts:
Industries
BioSymetrics is active in the following industries: